Pepeto announced today that its presale has surpassed $7.369 million with stages closing faster than any round before it. Staking deposits climb at 211% APY ahead of the approaching Binance listing. Three product demos are live at the Pepeto official website. SolidProof and Coinsult completed dual audits. An original Pepe cofounder is building this. The crypto news cycle keeps debating if XRP can reach $100, a target requiring $6 trillion in market cap. Meanwhile Pepeto sits at $0.000000186 where a $50 million cap returns 100x. The math tells the story.

Crypto News: XRP at $100 Requires $6 Trillion and Pepeto at $0.000000186 Requires One Good Listing
XRP hit its all time high of $3.65 in July 2025. Today it trades near $1.30, down 64%. As BeInCrypto reported, XRP remains in capitulation territory with most holders sitting on losses. The SEC lawsuit settled in August 2025 and six spot XRP ETFs launched with $1.4 billion in inflows. But none of that stopped the bleeding. As Zipmex confirmed, XRP reaching $100 requires a market cap of $6.09 trillion based on 60.9 billion circulating tokens. Most analysts call $100 an extremely long term target for 2035 at earliest. The realistic crypto news prediction: $3 to $8 by end of 2026. Even at $8, that’s 6x. Compare that to Pepeto. At $0.000000186, a $50 million cap returns 100x. Dogecoin hit $90 billion with a meme zero product. Pepeto has PepetoSwap for zero tax cross chain trading, Pepeto Bridge connecting Ethereum, BSC, and Solana, and Pepeto Exchange as a meme listing hub.

Crypto News: Pepeto Staking Outperforms XRP Returns While the Market Crashes Around Both
The crypto winter hit everything. Bitcoin is down 50% from $126,000. XRP is down 64% from $3.65. As Crypto.com reported, 62% of Polymarket users expect Bitcoin below $50,000 this year and $4.5 billion in ETF outflows hit since January. The Fear and Greed Index reads Extreme Fear. But fear at this level has never lasted. Every time the market reached this point, the recovery that followed created more millionaires than the bull run before it. And the ones who profited most were never the ones watching from the sidelines. They were already in. Pepeto holders have been earning through every red candle. At 211% APY on $100,000, staking pays $578 daily while XRP holders watch their portfolios shrink with no yield to soften the fall. XRP needs a $6 trillion miracle to reach $100. Pepeto needs one Binance candle. The presale just crossed $7.369 million and 74% is already filled. Three products are approaching launch in the middle of a market where most projects ship nothing but promises. That’s not hope. That’s traction during a downturn, and historically that’s the strongest signal there is. The crypto news cycle will flip bullish again. When it does, the six zero price at $0.000000186 won’t exist anymore. Visit the Pepeto official website while this window is still open.

Click To Visit Pepeto Website To Enter The Presale

Important Pepeto Presale Disclaimer
IMPORTANT: Pepeto is still in presale and NOT available on any exchange or DEX. As crypto news and XRP comparison articles drive attention, fake tokens appear daily. The ONLY way to buy Pepeto is through the Pepeto official website.

FAQs

Can XRP reach $100?
XRP at $100 requires a $6.09 trillion market cap, bigger than Apple and Microsoft combined. Analysts project $3 to $8 for 2026. Pepeto at $0.000000186 returns 100x at just $50 million cap.

Is Pepeto a better investment than XRP right now?
XRP needs $130 for 100x. Pepeto reaches 100x at a $50 million cap. Pepeto pays 211% APY staking while XRP has no staking. Visit the Pepeto official website to enter the presale.

How much does Pepeto staking pay daily?
At 211% APY, $100,000 in Pepeto staking generates $578 per day, $17,583 per month, and $211,000 per year. Rewards pay through crashes because presale tokens aren’t on exchanges.

What is the latest crypto news on Pepeto presale?
Pepeto surpassed $7.369 million raised with the presale 70% filled. Three product demos are live, dual audits complete, and the Binance listing approaches. Price remains $0.000000186 with 211% APY staking.

About Pepeto
Pepeto is a meme coin infrastructure project. PepetoSwap (zero tax cross chain trading), Pepeto Bridge (multi chain routing), Pepeto Exchange (meme listing hub). Pepe cofounder. Dual audits by SolidProof and Coinsult. Zero tax. 211% staking. Presale: $0.000000186. Raised $7.369M. Binance listing approaching.

CONTACT: MEDIA CONTACT
Contact: Dani Bonocci
Email: info@pepeto.io
Website: https://pepeto.io/
Phone: +971586738991

Pepeto just announced $7.368 million raised in presale funding while Ethereum dropped below $1,900 after US and Israeli strikes on Iran sent shockwaves through every exchange. Over $515 million in leveraged positions were liquidated in hours. ETH fell harder than Bitcoin because it trades as a risk asset during geopolitical shocks. But Pepeto holders lost nothing. Presale tokens do not sit on exchanges and cannot be liquidated. While ETH holders watched portfolios bleed, Pepeto stakers earned 211% APY through every second of the sell off. The biggest crypto news right now is not the ethereum price prediction debate. It is the fact that smart money is rotating into presale positions that pay daily yield at a price lower than the listing price.

Pepeto Presale Gains Traction as Ethereum Price Prediction Shows Long Term Strength               
Ethereum deserves the long term optimism. Buterin built the foundation that powers decentralized finance. As Yahoo Finance reported, Wall Street analysts see ETH reclaiming $5,000 this year. As CoinPedia noted, the bullish ethereum price prediction reaches $6,200 if ETH breaks $3,000. But those targets assume stability. Right now Iran is launching missiles at US bases, oil fears are spiking, and ETH sits at $1,800. Every geopolitical escalation since 2024 has hit Ethereum harder than Bitcoin.

Pepeto is not exposed to any of that. The presale price is locked at $0.000000186. It does not move with war headlines or get liquidated during cascades. The listing price after presale closes will be higher than what buyers pay today. Every presale investor enters at a guaranteed discount to exchange debut before any market action begins. That is a setup ETH cannot offer right now.

Ethereum still charges $5 to $50 per swap. There is no dedicated exchange for the $45 billion meme economy. Pepeto solved all three. PepetoSwap offers zero tax trading across ETH, BSC, and Solana. Pepeto Bridge moves tokens in seconds. Pepeto Exchange approaching launch creates a dedicated listing hub. DOGE hit $89 billion with zero products. SHIB hit $41 billion with one swap. Pepeto builds all three from day one.

Pepeto Staking Pays Daily as Crypto News Shows Ethereum Holders Waiting Months for Recovery
Here is why smart investors buy and stake Pepeto instead of holding ETH through a war cycle. $400,000 into ETH staking at 3.5% APY pays $14,000 a year while the token drops 10% in a weekend. The same $400,000 into Pepeto at 211% APY generates $844,000 in one year. $70,333 every month. $2,312 every day. The Pepeto team said it clearly: “Staking is made to surpass any classic investment like gold or real estate, and made to reward early believers and lock supply.” Stakers earn compounding returns at a price lower than listing, then capture the multiple once exchanges go live.

The ethereum price prediction on $400,000 is a move from $2,000 to $6,200, roughly 3x if everything goes right. But at a $50 million market cap, every dollar in Pepeto becomes $100. At $500 million, $1,000. PEPE crossed $7 billion with nothing but memes. A Pepe ecosystem cofounder backs Pepeto with three products, dual audits from SolidProof and Coinsult, and zero tax.

The presale on the Pepeto official website is 70% filled. The listing price is higher than the current entry. Staking compounds daily while you wait. And once exchanges list the token, the real multiples begin on top of a position that already grew through yield. The crypto news cycle is screaming fear. ETH holders are watching charts and hoping for peace. Pepeto holders are earning $2,312 a day and waiting for a listing candle that could deliver 100x or more. Visit the Pepeto official website before this stage closes.

Click To Visit Pepeto Website To Enter The Presale

FAQs

What is the biggest crypto news today? 
US and Israeli strikes on Iran crashed crypto markets with $515 million in liquidations. ETH dropped below $1,900 while Pepeto presale holders earned 211% APY unaffected.

What is the ethereum price prediction for 2026? 
Analysts target $5,000 to $6,200 for ETH long term, but geopolitical risk creates short term downside that presale positions like Pepeto avoid entirely.

Why are investors staking Pepeto instead of holding Ethereum? 
Pepeto staking pays 211% APY at a fixed price below listing price. Investors earn daily yield, enter cheaper than exchange debut, and capture multiples after launch. Visit the Pepeto official website for details.

Is Pepeto safe during a crypto market crash? 
Presale tokens cannot be liquidated on exchanges. With $7.368 million raised, dual audits, and a Pepe cofounder, the project offers crash protection with 100x plus upside after listing.

CONTACT: MEDIA CONTACT
Contact: Dani Bonocci
Email: info@pepeto.io
Website: https://pepeto.io/
Phone: +971586738991

Franklin, TN, Feb. 27, 2026 (GLOBE NEWSWIRE) — This article contains affiliate links. If a purchase is made through these links, a commission may be earned at no additional cost to the buyer. This article is an informational overview and does not constitute medical, health, or therapeutic advice. All product details described below are stated as presented by the company and should be verified directly on the official website before any purchasing decision.

If you’ve been looking for insoles that go beyond basic cushioning, you’ve probably come across Akusoli Shoe Insoles. The product has gained visibility among consumers searching for magnetic acupressure insoles that combine cushioning with magnetic elements and textured acupressure-inspired design features — particularly among adults who spend long hours standing, walking, or working on hard surfaces.

Search terms such as “Akusoli insoles effectiveness” and “do magnetic insoles work” often reflect two separate questions: whether the magnets add measurable benefit, and whether the insole’s cushioning and fit improve day-to-day comfort. This report looks at both.

Akusoli positions its insoles as a Japanese-inspired magnetic acupressure product designed to support everyday foot comfort, reduce pressure, and ease tired feet during daily wear. With growing consumer interest in whether magnetic insoles actually deliver on their marketed benefits and how acupressure-based shoe inserts compare to standard cushioned options, this report takes a closer look at what Akusoli states, what the broader research landscape supports, and what you should verify on your own before purchasing.

References to “effectiveness” throughout this report refer to everyday comfort experience, fit, materials, and the company’s stated design intent — not treatment of medical conditions. This article does not determine medical effectiveness.

This report does not recommend for or against Akusoli Shoe Insoles. It evaluates the company’s stated product features, the general research context for magnetic and acupressure insole technology, and the key details worth confirming independently.

Current product details, pricing, and terms can be confirmed by viewing the current Akusoli Shoe Insoles offer (official Akusoli page).

Individual results vary. Insoles are general wellness products and are not substitutes for professional medical evaluation, diagnosis, or treatment. Consult a qualified healthcare provider before relying on any insole product for management of diagnosed conditions.

What Are Akusoli Shoe Insoles

Akusoli Shoe Insoles are trim-to-fit magnetic acupressure insoles marketed for everyday use in work boots, sneakers, casual shoes, and other standard footwear. The company positions the insoles as featuring strategically placed magnets, textured acupressure cushion nodes, memory foam construction, and an antimicrobial silver coating designed to support foot hygiene.

According to the company’s published product information, the insoles are designed to distribute weight evenly across the foot, reduce pressure on specific areas, and provide cushioning that adapts to the natural contours of the wearer’s foot. The product comes in trim-to-fit sizing, with the S/M size fitting Women 5 through 10 and Men 5.5 through 7.5, and additional sizes available for larger feet.

Akusoli describes its insoles as drawing on Japanese-inspired wellness principles, specifically referencing the practice of foot acupressure — applying pressure to specific points on the sole of the foot. The company markets the insole’s magnetic elements as placed at pressure points corresponding to specific parts of the body, and describes the design as intended to provide a gentle massaging sensation during daily activities. This type of pressure-point mapping is commonly used in traditional wellness and reflexology-style marketing and should not be interpreted as a medically established mechanism.

The insoles are manufactured with a breathable, non-slip material that the product page describes as soft, flexible, and coated with antimicrobial silver to help maintain freshness. Akusoli also notes that the insoles are machine washable.

Magnetic Insoles Evidence Check: What Research Has and Hasn’t Shown

Before evaluating any specific magnetic insole product, it helps to understand where the research actually stands. The magnetic component is the claim that sets products like Akusoli apart from standard cushioned insoles — so it’s worth knowing what controlled studies have found.

Published randomized controlled trials have evaluated static magnets embedded in cushioned insoles. In multiple studies, the magnetic component has not consistently shown measurable differences compared with identical non-magnetic cushioned insoles. At the same time, many participants reported comfort improvements in both groups, which suggests cushioning quality, fit, and individual factors may account for much of the reported benefit.

That’s an important distinction. It doesn’t mean a product like Akusoli can’t feel good on your feet. It means the comfort you experience may come from the cushioning, arch support, and pressure distribution rather than the magnets specifically. The physical construction of the insole still matters — and that’s worth keeping in mind when evaluating any magnetic insole product.

On acupressure and reflexology: Foot acupressure and reflexology are traditional wellness practices with historical roots in Eastern medicine. Some published studies have examined practitioner-applied acupressure for relaxation and comfort, with mixed results. Insole-based acupressure applies constant, fixed pressure rather than the precise, varying pressure a trained practitioner uses — so research on practitioner-applied techniques doesn’t directly validate insole-based delivery.

On cushioning and arch support: Well-constructed insoles with proper cushioning and arch support can help distribute weight more evenly, reduce pressure concentration on specific areas, and provide a more comfortable surface during long shifts or extended walking. These mechanical comfort benefits are broadly supported by podiatric research and exist independently of magnetic or acupressure features.

Consumers researching terms such as “Akusoli insoles effectiveness,” “do magnetic insoles work,” “acupressure insoles evidence,” or “magnetic insoles for standing all day” should understand that the magnetic and acupressure claims represent the company’s product positioning, while published clinical evidence for static magnetic insoles specifically remains limited. The physical cushioning and support features may independently contribute to whatever comfort improvements a user experiences.

What Akusoli States About Its Magnetic and Acupressure Design

Here is what appears on the company’s official product pages and listings, attributed directly to Akusoli:

The company states that the magnets are intended to provide a constant, gentle massage-like feel during everyday wear, and that the raised acupressure nodes are designed to create a textured comfort sensation underfoot. The acupressure cushion nodes are described as targeting the most important areas of the feet to support comfort. The insoles also feature an antimicrobial silver coating that Akusoli says helps combat bacteria buildup and reduce foot odor. The overall design is marketed as adapting to the wearer’s foot contours for a personalized fit.

These are the company’s descriptions of its product. They have not been independently tested or verified by this publication, and these statements reflect the company’s marketing descriptions rather than established medical outcomes.

Akusoli Shoe Insoles Design and Construction Features

Based on the company’s published product descriptions and available marketplace listings, here is what the insoles include:

Magnetic elements: The product page references carefully placed magnets positioned at pressure points on the insole surface. The number, strength, and specific placement configuration of the magnets are not disclosed in publicly available specifications.

Acupressure cushion nodes: Textured raised areas designed to apply gentle pressure to the sole of the foot during wear. Per published descriptions, these are positioned to target key areas of the foot.

Memory foam construction: Product listings describe the insoles as memory foam insoles designed to adapt to the contours of the wearer’s foot over time.

Antimicrobial silver coating: Per published product descriptions, the insoles feature a silver-coated spandex material designed to help reduce bacterial buildup and foot odor.

Trim-to-fit design: The insoles can be cut to fit the wearer’s shoe size, with sizing guidelines provided for both men’s and women’s shoe ranges.

Breathable construction: Published product materials describe the insole materials as soft, flexible, and breathable, designed to keep feet cool and dry during extended wear.

Akusoli Shoe Insoles Pricing and Purchase Structure

Pricing is presented in multi-pair packages on the official website, with per-pair cost varying by bundle size. The company presents multiple bundle options, with per-pair pricing varying by package size.

All purchases are described as one-time payments with no subscription or auto-rebilling. The product is also listed through third-party marketplaces including Amazon and Walmart, though Akusoli encourages purchasing through the official website to ensure authenticity and full warranty coverage.

Consumers can verify current pricing and availability directly. Listed terms may change at any time, so confirming current details is recommended by viewing the current Akusoli Shoe Insoles offer (official Akusoli page).

Akusoli Shoe Insoles Return Policy and 60-Day Guarantee

Akusoli’s published return policy describes a 60-day return window from delivery for eligible returns initiated through customer support, with an RMA requirement and return-shipping procedures described in its policy materials. Because policies can be updated, consumers should review the current return terms on the official website and keep order confirmation and tracking documentation.

The return process involves contacting Akusoli’s customer support within the 60-day window, receiving a Return Merchandise Authorization (RMA) form, and shipping the product back using a trackable shipping method. Per the published policy, returns sent without a valid RMA may not be accepted. The return shipping address is listed as QuickBox Fulfillment, 415 Hamburg Turnpike, Building B, Wayne, NJ 07470.

Refunds are processed after the returned product is received and inspected. The company indicates that processing may take up to 14 business days, and that funds may take several additional business days to appear in the buyer’s account depending on the payment method and financial institution. Shipping fees are described as non-refundable unless the return is due to a company error or product defect.

Purchases made through third-party retailers such as Amazon or Walmart are subject to those platforms’ separate return policies.

What to Verify Before Buying Any Magnetic Acupressure Insole (Akusoli Included)

Confirm sizing and trim-to-fit compatibility. Akusoli insoles are designed to be trimmed to fit. Before purchasing, verify that the available size range matches your shoe size, and check whether your preferred footwear has removable insoles that can be swapped out for a proper fit.

Confirm materials and coating claims. If antimicrobial properties, silver coating, or specific foam types are important to your decision, consider contacting the company for specific material documentation beyond what appears on the product page.

Confirm return window and RMA steps. Akusoli’s published policy describes a 60-day return window with an RMA requirement. Verify the current terms directly, understand the return shipping steps, and note that shipping costs for returns are your responsibility unless the return is due to a company error.

Compare comfort criteria across sources. Consumers who rely on reviews when evaluating insoles may want to compare feedback across multiple retail and marketplace channels — Amazon, Walmart, Trustpilot — and focus on fit, durability, and comfort feel rather than outcome-based claims.

Use the evidence boundary. The comfort you experience from any magnetic insole product may come from the cushioning and construction features rather than the magnets specifically. That’s not a reason to avoid the product — it’s a reason to evaluate it based on how it feels on your feet rather than on magnetic therapy marketing alone.

Consult a healthcare professional for diagnosed conditions. Clinically diagnosed foot conditions require professional evaluation. Insoles — magnetic or otherwise — are not a substitute for professional care, and any persistent discomfort should be discussed with a qualified podiatrist or healthcare provider.

Who Might Consider Akusoli Shoe Insoles in 2026

Akusoli is marketed for people who are on their feet for long periods and want additional cushioning in work shoes, boots, or everyday footwear. Based on the product’s published positioning, the insoles may be of interest to adults looking for a cushioned, trim-to-fit option with additional magnetic and acupressure-inspired design elements as a general comfort upgrade.

The product may be less suited for consumers who require medically prescribed orthotic insoles for diagnosed biomechanical conditions, individuals who specifically need products with strong clinical evidence behind therapeutic claims, or those looking for insoles designed for high-impact athletic performance.

As with any consumer comfort product, individual satisfaction depends on personal factors including foot shape, arch height, body weight, daily activity levels, and shoe compatibility. The best way to evaluate any insole is how it feels on your feet during the activities you actually do — not based on marketing language alone.

Individuals with implanted electronic medical devices should consult a qualified healthcare professional before using products that contain magnets.

Consumer Questions About Akusoli Shoe Insoles

What are Akusoli Shoe Insoles made of?

According to the published product listing, the insoles feature memory foam construction with a breathable, non-slip spandex material coated with antimicrobial silver. Embedded magnetic elements and raised acupressure nodes are integrated into the insole surface. The specific materials list beyond these descriptions is not fully disclosed in publicly available specifications.

Are Akusoli Shoe Insoles classified as a medical device?

Akusoli is marketed as a consumer comfort product rather than a prescription orthotic. Questions about regulatory classification can be directed to the company.

Do magnetic insoles provide measurable comfort benefits beyond regular cushioned insoles?

Across controlled studies evaluating static magnetic insoles, the magnetic component has not consistently demonstrated measurable differences compared with non-magnetic cushioned insoles. That said, both magnetic and non-magnetic cushioned insoles showed comfort improvements in study participants — suggesting that the cushioning, arch support, and fit of the insole itself play the primary role. Whether the magnetic and acupressure elements add subjective value beyond that is a matter of personal experience.

How long do Akusoli Shoe Insoles last?

The product page describes the insoles as crafted with durable materials designed for daily use. Specific expected lifespan estimates are not provided in the company’s published materials. As with most insole products, longevity depends on how often you wear them, your activity level, and how you care for them.

Can I use Akusoli insoles in any type of shoe?

Akusoli markets the insoles as compatible with most shoe types, including sneakers, casual shoes, work boots, and boots. The trim-to-fit design allows customization, though the company recommends using them in shoes with removable insoles for the best fit.

Are there safety considerations with magnetic insoles?

Static magnetic products are generally considered low risk for most adults. However, individuals with implanted electronic medical devices should consult a qualified healthcare professional before use. Anyone experiencing increased discomfort while wearing magnetic insoles should discontinue use and seek professional guidance.

Where can I buy authentic Akusoli Shoe Insoles?

The insoles are available through the official website at get-akusoli.com as well as through Amazon and Walmart. Akusoli encourages purchasing through the official website to ensure product authenticity and full warranty eligibility.

How does Akusoli compare to prescription orthotic insoles?

Akusoli Shoe Insoles are consumer wellness insoles featuring magnetic and acupressure design elements. Prescription orthotics are custom-fitted devices designed to address specific biomechanical conditions under professional guidance. These are different product categories that serve different needs.

What is the difference between Akusoli insoles and regular foam insoles?

Standard foam insoles provide cushioning and basic support. Akusoli adds embedded magnets and textured acupressure nodes to a memory foam base. Whether these additional elements provide measurable comfort benefits beyond what the cushioning alone delivers depends on individual experience — and published research on the magnetic component has shown limited additional benefit in controlled settings.

Is insole-based acupressure the same as professional acupressure?

They are different applications of the same concept. Professional acupressure involves a trained practitioner applying precise, varying pressure to specific points for defined durations. Insole-based acupressure applies constant pressure through fixed raised nodes determined by your body weight and foot positioning. Research findings on one delivery method should not be assumed to apply directly to the other.

Can magnetic acupressure insoles help with everyday foot discomfort from long shifts?

Any well-constructed cushioned insole with proper arch support may help reduce discomfort during prolonged standing or walking on hard surfaces. That benefit comes primarily from the cushioning and weight distribution features. Whether the magnetic and acupressure elements of a product like Akusoli contribute additional subjective comfort beyond the physical construction depends on individual experience. For persistent or worsening discomfort, professional evaluation is recommended.

Does Akusoli offer international shipping?

The company’s website indicates that shipping availability may vary by region. Checking current shipping options and associated costs on the official website before ordering is recommended.

Additional Consumer Research

Consumers researching Akusoli Shoe Insoles may benefit from reviewing previously published independent reporting on this product. A 2025 consumer overview examining Akusoli magnetic acupressure insole features, design claims, and product positioning provides additional context on how the product has been presented to consumers over time.

Independent research across multiple consumer publications, podiatric resources, and peer-reviewed sources may provide broader perspective on magnetic insoles, acupressure-based foot products, and evidence-based approaches to foot comfort. Evaluating multiple sources is recommended before making any purchasing decision. Consumers may also wish to review guidance from the American Podiatric Medical Association on insole selection and foot health.

Summary of Key Considerations

Akusoli Shoe Insoles are a consumer wellness product that combines cushioned memory foam construction with embedded magnetic elements and acupressure-style textured nodes. The company positions the product as a Japanese-inspired foot comfort solution for everyday wear in work boots, sneakers, and casual shoes. Features such as antimicrobial silver coating, trim-to-fit sizing, and breathable materials may contribute to general foot comfort independently of the magnetic and acupressure components.

The controlled research on static magnetic insoles has not demonstrated measurable additional comfort benefits from the magnetic component specifically — but participants in those studies did report comfort improvements from cushioned insoles regardless of whether magnets were present. The acupressure design elements represent a different delivery method than practitioner-applied acupressure, and research on one should not be assumed to validate the other. The physical cushioning, arch support, and pressure redistribution features of the insole may be the primary drivers of whatever comfort a user experiences.

The company’s published return policy describes a 60-day return window with an RMA requirement. The product is also available through Amazon and Walmart under those platforms’ respective return policies.

Complete product details, current pricing, and published terms are available by viewing the current Akusoli Shoe Insoles offer (official Akusoli page).

Contact Information

Company: Akusoli Shoe Insoles

Address: 354 Downs Blvd, Suite 101A, Franklin, TN 37064

Support Email: support@akusoli.com

Online Contact Form: https://get-akusoli.com/contact

Phone: +1 (682) 228-2210

Fulfillment: QuickBox Fulfillment, 415 Hamburg Turnpike, Building B, Wayne, NJ 07470

Disclaimers

Content and Consumer Information Disclaimer: This article is an independent informational overview and does not constitute medical, health, therapeutic, or legal advice. All product details, design descriptions, pricing, and policy terms described in this article are stated as presented by the company on its publicly available website and product listings. This content has not been independently audited or verified unless specifically noted. Readers are encouraged to verify all claims directly with the manufacturer and to consult a qualified healthcare professional regarding any diagnosed conditions.

Health and Wellness Product Notice: Akusoli Shoe Insoles are marketed as general wellness and comfort products. The company’s own published disclaimer states that Akusoli products are not intended to diagnose, treat, cure, or prevent any specific disease or condition. Individual results vary based on numerous factors including foot structure, body weight, daily activity, shoe type, and consistency of use. Persistent foot discomfort or diagnosed conditions should be discussed with a qualified podiatrist or healthcare provider.

Results, Pricing, and Product Variability: All pricing, promotional offers, shipping terms, and return policies referenced in this article are based on information published on the official product website and third-party marketplace listings at the time of writing and may change without notice. Consumers should verify current terms through the official website or their chosen retailer before completing any purchase.

FTC Affiliate Disclosure and Publisher Responsibility: This article contains affiliate links. If a product is purchased through these links, a commission may be earned at no additional cost to the buyer. The publisher of this article is not responsible for typographical errors, manufacturer changes to the product after publication, or individual consumer outcomes.

CONTACT: Support Email: support@akusoli.com
Online Contact Form: https://get-akusoli.com/contact
Phone: +1 (682) 228-2210

Tallmadge, OH, Feb. 27, 2026 (GLOBE NEWSWIRE) — Disclaimer: This article is for informational purposes only. It is not medical advice. Always consult a qualified healthcare professional before starting supplements. If you purchase through links in this article, a commission may be earned at no additional cost to you.

This article is an informational overview and does not constitute medical, health, or dietary advice. Product details, pricing, and policies referenced below are presented as stated by the company and should be verified directly on the official website before any purchasing decision.

In this report, terms such as “results,” “support,” or “effectiveness” refer strictly to how Sugar Harmony Drops’ marketing materials describe potential outcomes. These terms do not indicate that Sugar Harmony Drops has been clinically proven effective as a finished proprietary formula.

Consumer interest in metabolic wellness supplements has continued to grow in early 2026, particularly among adults managing daily energy fluctuations and looking for alternatives to traditional capsule-based formulations. Many consumers researching this category use phrases such as “blood sugar support supplement” when comparing ingredient lists, terms, and disclaimers. Sugar Harmony Drops is one of the liquid supplement products generating search activity in this space — and with that visibility come practical questions about what’s actually in the formula, how the cited research should be interpreted, and how the pricing and return policies work in practice.

This report does not recommend for or against Sugar Harmony Drops. It evaluates what the company states, what ingredient-level research indicates in published studies, and what is not established at the finished-product level.

Current product details, pricing, and terms can be confirmed by viewing the current Sugar Harmony Drops offer (official Sugar Harmony Drops page).

Individual results vary. Dietary supplements are not substitutes for balanced nutrition, regular physical activity, or professional medical guidance. Consult a qualified healthcare provider before starting any new supplement regimen, particularly if you are currently managing an existing health condition or taking prescription medications.

What Is Sugar Harmony Drops

Sugar Harmony Drops is a liquid dietary supplement marketed as a wellness support formula containing all-natural ingredients. The company sells it as a daily liquid drop and positions it as a plant-based option for adults interested in metabolic and overall wellness support. The product is distributed by SugarHarmony Research, with payments processed through ClickBank as the authorized retailer.

Per publicly available information, Sugar Harmony Drops is described as containing a blend of natural vitamins and extracts in a liquid format designed for daily use. The company markets the product as suitable for both men and women. Each bottle is listed as containing 2 fluid ounces, which equates to a 30-day supply at the recommended serving size.

Publicly available materials reference a multi-step process that begins with selecting a pricing package, though specific usage instructions beyond daily consumption are not detailed. Marketplace listings associate the product with the brand name Syvor, while the official website operates under the SugarHarmony Research name.

Sugar Harmony Drops is a dietary supplement. Under current federal regulations, dietary supplements are not required to receive FDA approval before being sold. The FDA does not evaluate supplement efficacy claims prior to market entry. The company’s own website includes the standard disclaimer that statements have not been evaluated by the Food and Drug Administration and that the product is not intended to diagnose, treat, cure, or prevent any disease.

Sugar Harmony Drops Ingredient Profile: What the Product Page Discloses

The official website’s references section lists 32 scientific citations corresponding to ingredients associated with the formula. Referenced ingredients include Gymnema Sylvestre, Chromium Picolinate, Bitter Melon, Cinnamon Extract, Green Tea Catechins, Astragalus Membranaceus, Grape Seed Extract, Forskolin, Korean Ginseng, Ashwagandha, Capsaicin, GABA, L-Carnitine, African Mango, and additional botanicals and amino acids.

Several of these ingredients have been individually studied in published peer-reviewed research for properties related to glucose-related metabolic parameters and general metabolic wellness, depending on study design and participant population. Gymnema Sylvestre has been examined in nutrition research for its potential effects on glucose uptake. Chromium Picolinate has been studied in relation to glucose metabolism, though findings vary across studies and dosages. Cinnamon and Bitter Melon each appear in metabolic health literature with varying degrees of evidence.

The key consideration for anyone evaluating this formula is dosage transparency. The official product page and marketplace listings describe the formula as containing “all natural ingredients” and “maximum strength premium vitamins,” but publicly available materials don’t appear to disclose the specific amount of each individual ingredient per serving.

That matters because published studies on individual compounds often use specific dosage ranges depending on study design. Because Sugar Harmony Drops does not publicly disclose per-ingredient amounts, readers may not be able to compare the formula’s per-serving quantities to the dosing used in individual research studies. This does not establish that the product has or lacks effect — it means ingredient citations cannot be mapped to serving-level amounts based on publicly available labeling.

Marketing Claims: What Is Stated vs. What Can Be Verified

Sugar Harmony Drops is marketed using language that describes the formula as supporting an active lifestyle, containing maximum strength ingredients, promoting overall well-being, and being crafted with carefully selected natural ingredients. Publicly available marketing materials also reference a satisfaction guarantee and describe the product as providing consistent daily use over a full month.

The company’s references section cites 32 published studies from journals including the Journal of Ethnopharmacology, Diabetes Care, and American Journal of Clinical Nutrition. Those are real peer-reviewed publications that examined individual compounds under specific research conditions. But there’s an important distinction to understand before connecting that research to this specific product.

The studies cited examined isolated ingredients at known dosages in controlled research settings. They didn’t evaluate Sugar Harmony Drops as a finished multi-ingredient liquid supplement. Publicly available sources reviewed for this report do not indicate a published clinical study evaluating Sugar Harmony Drops as a finished proprietary formula.

Consumers researching phrases such as “Sugar Harmony Drops blood sugar results,” “does Sugar Harmony work,” “SugarHarmony effectiveness,” or “Sugar Harmony Drops ingredients research” should understand that marketing claims referencing published studies describe ingredient-level findings, not product-level clinical outcomes. That’s standard across the dietary supplement industry, but it’s especially important to understand in this category where consumers may be making health-related purchasing decisions.

This evaluation doesn’t conclude whether Sugar Harmony Drops has or lacks utility as a wellness supplement. It focuses on clarifying how the performance-related marketing language should be interpreted when you’re doing your own research.

Sugar Harmony Drops Pricing and Purchase Structure

According to pricing information published on the official website at the time of this report, Sugar Harmony Drops is presented in multi-bottle packages. The 6-bottle option is listed at $49 per bottle ($294 total) with free shipping and is described as a 180-day supply. The 3-bottle option is listed at $69 per bottle ($207 total) with free shipping and is described as a 90-day supply. The 2-bottle option is listed at $79 per bottle ($158 total) with $9.99 shipping and is described as a 60-day supply.

All purchases are processed through ClickBank. Pricing listed on the official website describes these as one-time purchases.

Consumers considering the 6-bottle package should be aware of a fulfillment detail described in the company’s Terms of Service. Per the published terms, the 6-bottle offer includes an additional fulfillment step: only three bottles are shipped initially, and the remaining three require the buyer to scan a QR code included with the shipment and submit information within 60 days of the original purchase date. Readers should review current terms directly on the official site before selecting this package.

This offer includes an additional fulfillment step described in the Terms of Service. Pricing and availability may change, and consumers can confirm current terms directly on the official site by viewing the current Sugar Harmony Drops offer (official Sugar Harmony Drops page).

Sugar Harmony Drops Refund Policy and 60-Day Guarantee

The company’s published refund policy states that consumers are covered by a 60-day satisfaction guarantee from the date the order is shipped. If you’re unsatisfied within the first 60 days, you can request a full refund by contacting the support team.

The refund process requires returning all bottles — whether empty, full, or partially full — including any bonus or free bottles. Returns must be sent to the company’s Tallmadge, Ohio fulfillment address with a written note including the order ID, full name, address, email, and phone number. The buyer is responsible for return shipping costs and must provide a tracking number. The company states that consumers should contact support before initiating a return. Refund timelines depend on the buyer’s financial institution. Requests can also be initiated through ClickBank’s self-service portal.

Sugar Harmony Drops Marketing Disclosures: What Consumers Should Know

Official marketing materials include messaging that describes the formula as supporting well-being and complementing health journeys. The company’s disclaimer section states that testimonials, case studies, and examples are results forwarded by users and are not intended to represent or guarantee that anyone will achieve the same or similar outcomes.

Consumers should ensure that promotional content they encounter originates from official brand channels. As with many products advertised online, third-party ads or intermediary pages may circulate that do not necessarily reflect the company’s official messaging or current terms. If you discover a product through social media advertising, confirm the details directly on the official website before making a purchasing decision.

The company’s own Terms of Service include standard disclaimers noting that product information is provided on an “as is” basis and that readers should confirm information with other sources and consult healthcare providers.

Understanding the Difference Between Ingredient Research and Product Research

This is one of the most useful things to understand when evaluating any supplement, and it applies broadly — not just to Sugar Harmony Drops.

Some supplements are evaluated in controlled studies as finished formulations, while others cite research on individual ingredients. Publicly available sources reviewed for this report do not indicate a published clinical study evaluating Sugar Harmony Drops as a finished proprietary formula. The research cited on the product website pertains to individual ingredients tested in isolation, often at dosages that may differ from what the liquid formulation delivers.

Knowing this distinction helps clarify what is established at the ingredient level versus what has not been established at the finished-product level. The type of evidence that would confirm product-level outcomes — a controlled trial of the finished formula — hasn’t been publicly located. That’s something to factor into your decision alongside the other information in this report.

How to Evaluate a Supplement Like This Before Buying

Check whether individual ingredient dosages are disclosed. Full-disclosure labeling lets you and your healthcare provider compare what’s in each serving against published research. When specific amounts aren’t listed, consider contacting the manufacturer directly.

Understand the difference between ingredient research and product research. Many supplements reference published studies on individual compounds. Fewer have been tested as finished formulations. Knowing which type of evidence you’re looking at helps set realistic expectations.

Read the terms of service and disclaimer pages. Important information about fulfillment procedures, refund requirements, and how the company characterizes expected results is often found in the fine print rather than on the main product page.

Verify that promotional content comes from official channels. If you discover a product through social media, confirm the details directly on the company’s official website before purchasing. Third-party advertising may not reflect current product terms.

Talk to your healthcare provider first. This is especially important if you’re taking prescription medications or managing an existing health condition. A qualified clinician familiar with your personal medical history is the most reliable resource for evaluating whether any supplement is appropriate for you.

Who Might Consider Sugar Harmony Drops in 2026

Based on how the product is positioned and what’s publicly available about its ingredient profile, Sugar Harmony Drops may appeal to adults who prefer liquid supplement formats. It may also interest consumers exploring natural ingredient-based options as one part of a broader wellness approach that includes balanced nutrition, regular physical activity, and guidance from a healthcare provider.

It may be less suited for consumers who need transparent individual ingredient dosing to make clinical comparisons, those who require medically validated interventions for a diagnosed condition, or anyone expecting significant changes from a single supplement without accompanying lifestyle modifications. As with all dietary supplements, individual outcomes depend on personal health factors, and the FDA does not evaluate supplement efficacy claims before products reach the market.

Consumer Questions About Sugar Harmony Drops

What is Sugar Harmony Drops?

Sugar Harmony Drops is a liquid dietary supplement marketed as a metabolic wellness supplement. Company materials associate the product with glucose-related wellness messaging, and consumers are encouraged to review the company’s disclaimers and terms directly before purchase. It is sold through the official website at getsugarharmony.com and processed through ClickBank. The product is described as containing all-natural ingredients in a liquid drop format designed for daily use.

Is Sugar Harmony Drops FDA approved?

Sugar Harmony Drops is a dietary supplement. Under current federal regulations, dietary supplements do not require FDA approval before being sold. The FDA does not evaluate supplement efficacy claims. The company’s website includes the standard FDA disclaimer that the product is not intended to diagnose, treat, cure, or prevent any disease.

What ingredients are in Sugar Harmony Drops?

Referenced ingredients include Astragalus, Grape Seed Extract, Gymnema Sylvestre, Green Tea Catechins, Cinnamon, Bitter Melon, Chromium Picolinate, Korean Ginseng, Forskolin, Ashwagandha, and others. Individual ingredient dosages per serving do not appear to be publicly disclosed on the product label or website.

Does Sugar Harmony Drops have published clinical trials?

No published clinical trial appears to evaluate Sugar Harmony Drops as a finished proprietary formula. The scientific references on the product website correspond to studies on individual ingredients tested in isolation under specific research conditions.

How long does it take to see results with Sugar Harmony Drops?

Publicly available marketing materials do not appear to specify a defined timeline for expected outcomes. Individual timelines depend on numerous factors including baseline metabolic health, dietary habits, physical activity, and consistency of use. The company’s disclaimer notes that results forwarded by users are not intended to guarantee similar outcomes for all purchasers.

What is the Sugar Harmony Drops refund policy?

The published policy provides a 60-day window from the shipping date for refund requests. All bottles must be returned to the Tallmadge, Ohio address. The buyer covers return shipping and must provide a tracking number. Contact support before initiating returns. Processing timelines depend on the buyer’s financial institution.

How does the 6-bottle fulfillment work?

Per the company’s Terms of Service, the 6-bottle package ships only three bottles initially. The buyer must scan a QR code included with the shipment, submit personal details on a secure webpage, and request the remaining three bottles within 60 days of the original purchase. Failure to complete this process within the stated period may result in forfeiture of the remaining bottles.

Who manufactures Sugar Harmony Drops?

Marketplace listings associate the product with the brand name Syvor, while the official website operates under SugarHarmony Research. The fulfillment address is in Tallmadge, Ohio. Specific manufacturing facility details, including GMP certification status, are not prominently disclosed on the official website.

Is Sugar Harmony Drops suitable for both men and women?

Official marketing describes Sugar Harmony Drops as containing premium vitamins for women and men. Published research on individual ingredients has included both male and female study participants. Adults considering this product should consult a healthcare provider, particularly if taking medications or managing existing health conditions.

Where is Sugar Harmony Drops sold?

The official product website is getsugarharmony.com. Purchases are processed through ClickBank. The product also appears on marketplace platforms including Amazon under the Syvor brand name. The company advises verifying product authenticity when purchasing through any channel.

Additional Consumer Research

Independent research across multiple consumer publications and peer-reviewed sources may provide broader perspective on metabolic wellness supplements, liquid supplement bioavailability, and the specific ingredients referenced in Sugar Harmony Drops. Evaluating multiple sources is recommended before making any purchasing decision. Consumers may also wish to review the FDA’s general guidance on dietary supplement labeling and claims.

Summary of Key Considerations

Sugar Harmony Drops is a liquid dietary supplement positioned in the wellness support category with ingredient references that include Gymnema Sylvestre, Chromium Picolinate, Cinnamon, Bitter Melon, and additional botanicals. The product references ingredients with published research at the individual compound level. However, individual ingredient dosages per serving don’t appear to be publicly disclosed, and publicly available sources do not indicate a published clinical study evaluating the finished product as formulated.

The company provides a 60-day refund guarantee processed through ClickBank, with multi-bottle pricing starting at $49 per bottle for the 6-bottle package. The 6-bottle fulfillment structure includes an additional QR code activation step described in the Terms of Service. Marketing disclaimers on the official website note that the product has not been evaluated by the FDA and that individual results may vary.

For consumers who want to review the full product details directly, complete product information, current pricing, and published terms are available by viewing the current Sugar Harmony Drops offer (official Sugar Harmony Drops page).

Contact Information

Company: SugarHarmony Research

Return Address: 285 Northeast Ave, Tallmadge, OH 44278

Email: support@getsugarharmony.com

Website: getsugarharmony.com

Payment Processor: Click Sales Inc., 1444 S. Entertainment Ave., Suite 410, Boise, ID 83709

Self-Service Billing Support: https://www.clkbank.com/

Disclaimers

Content and Consumer Information Disclaimer: This article is an independent informational overview and does not constitute medical, health, dietary, financial, or legal advice. All product details, ingredient information, pricing, and policy terms described in this article are stated as presented by the company on its publicly available website and product labeling. This content has not been independently audited or verified unless specifically noted. Readers are encouraged to verify all claims directly with the manufacturer and to consult a qualified healthcare professional before beginning any dietary supplement.

Supplement and Health Notice: Dietary supplements are not intended to diagnose, treat, cure, or prevent any disease. The statements made by the manufacturer regarding this product have not been evaluated by the Food and Drug Administration. Individual results vary based on numerous factors including age, baseline health, dietary habits, activity level, and consistency of use. Health and wellness concerns should be discussed with a qualified healthcare provider who is familiar with the individual’s personal medical history.

Results, Pricing, and Product Variability: All pricing, bonus offers, shipping terms, and refund policies referenced in this article are based on information published on the official product website at the time of writing and may change without notice. Consumers should verify current terms through the official website or the authorized payment processor before completing any purchase.

FTC Affiliate Disclosure and Publisher Responsibility: This article contains affiliate links. If a product is purchased through these links, a commission may be earned at no additional cost to the buyer. Click Sales Inc. (ClickBank) serves as the authorized payment processor for this product. ClickBank’s role as retailer does not constitute an endorsement, approval, or review of this product or any claim, statement, or opinion used in its promotion. The publisher of this article is not responsible for typographical errors, manufacturer changes to the product after publication, or individual consumer outcomes.

CONTACT: Email: support@getsugarharmony.com

IF YOU SUFFERED A LOSS ON YOUR NUSCALE INVESTMENTS, CLICK HERE TO INQUIRE ABOUT POTENTIALLY PURSUING CLAIMS TO RECOVER YOUR LOSS UNDER THE FEDERAL SECURITIES LAWS.

What Happened?
On November 6, 2025, after market hours, NuScale disclosed that the Company’s general and administrative expenses had increased more than 3,000%, to $519 million during its third fiscal quarter compared to $17 million in the prior year period. The surge was largely due to the Company’s payment of $495 million to ENTRA1 Energy LLC for its Tennessee Valley Authority agreement. As a result, NuScale’s quarterly net loss rose to $532 million, up from $46 million in the prior year period.

Following the Company’s earnings announcement, analysts at Guggenheim Securities published a report stating that ENTRA1 was a “3-year old company that has never built, financed or operated anything” and that its available information revealed nothing “regarding the company’s history, management team, size or capitalization.” The report further stated that a “more accurate description” of ENTRA1 would be “that it is an entity supporting the activities of a single individual, specifically [its CEO and Chairman, Wadie Habboush].”

On this news, NuScale’s stock price fell $4.03, or 12.4%, over two consecutive trading days to close at $28.43 per share on November 10, 2025, thereby injuring investors.

What Is The Lawsuit About?
The complaint filed in this class action alleges that throughout the Class Period, Defendants made materially false and/or misleading statements, as well as failed to disclose material adverse facts about the Company’s business, operations, and prospects. Specifically, Defendants failed to disclose to investors that: (1) ENTRA1 had never built, financed, or operated any significant projects—let alone projects in the highly technical and complicated field of nuclear power generation—during its entire operating history; (2) NuScale had entrusted its commercialization, distribution, and deployment of its NuScale Power Modules, and hundreds of millions of dollars of NuScale capital to an entity that lacked any significant prior experience owning, financing, or operating nuclear energy generation facilities; (3) the purported experience and qualifications attributed to ENTRA1 by defendants during the Class Period in fact referred to the purported experience and qualifications of the principals of the Habboush Group, a distinct entity without significant experience in the field of nuclear power generation; (4) as a result, NuScale’s commercialization strategy was exposed to material, undisclosed risks of failure, delays, regulatory challenges, or other negative setbacks; and (5) as a result, Defendants’ positive statements about the Company’s business, operations, and prospects were materially misleading and/or lacked a reasonable basis at all relevant times.

If you purchased or otherwise acquired NuScale common stock during the Class Period, you may move the Court no later than April 20, 2026 to request appointment as lead plaintiff in this putative class action lawsuit.

Contact Us To Participate or Learn More:
If you wish to learn more about this action, or if you have any questions concerning this announcement or your rights or interests with respect to these matters, please contact us:
Charles Linehan, Esq.,
Glancy Prongay Wolke & Rotter LLP,
1925 Century Park East, Suite 2100,
Los Angeles California 90067
Email:  shareholders@glancylaw.com
Telephone: 310-201-9150,
Toll-Free: 888-773-9224
Visit our website at www.glancylaw.com.
Follow us for updates on LinkedIn, Twitter, or Facebook.

If you inquire by email, please include your mailing address, telephone number and number of shares purchased.

To be a member of the class action you need not take any action at this time; you may retain counsel of your choice or take no action and remain an absent member of the class action.
This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.

Contact Us:
Glancy Prongay Wolke & Rotter LLP,
1925 Century Park East, Suite 2100
Los Angeles, CA 90067
Charles Linehan
Email:  shareholders@glancylaw.com
Telephone: 310-201-9150
Toll-Free: 888-773-9224
Visit our website at: www.glancylaw.com.

IF YOU SUFFERED A LOSS ON YOUR KYNDRYL INVESTMENTS, CLICK HERE TO INQUIRE ABOUT POTENTIALLY PURSUING CLAIMS TO RECOVER YOUR LOSS UNDER THE FEDERAL SECURITIES LAWS.

What Happened?
On February 9, 2026, Kyndryl announced the Company’s CFO and General Counsel had both departed “effective immediately.” The Company also announced that it would be unable to timely file its quarterly report and that it “is reviewing its cash management practices related disclosures” as well as “the efficacy of the Company’s internal control over financial reporting, and certain other matters following the Company’s receipt of voluntary document requests from the Division of Enforcement of the Securities and Exchange Commission (“SEC”) relating to such matters.”

The Company further announced it “anticipates reporting material weaknesses in the Company’s internal control over financial reporting” which is expected to include at minimum “the effectiveness and strength of certain functions at the Company, including with respect to controls related to information and communication and tone at the top.”

On this news, Kyndryl’s stock price fell $12.90, or 54.9%, to close at $10.59 per share on February 9, 2026, thereby injuring investors.

What Is The Lawsuit About?
The complaint filed in this class action alleges that throughout the Class Period, Defendants made materially false and/or misleading statements, as well as failed to disclose material adverse facts about the Company’s business, operations, and prospects. Specifically, Defendants failed to disclose to investors that: (1) Kyndryls financial statements issued during the Class Period were materially misstated; (2) Kyndryl lacked adequate internal controls and at times materially understated issues with its internal controls; (3) as a result, Kyndryl would be unable to timely file its Quarterly Report on Form 10-Q for the quarter ended December 31, 2025; and (4) as a result, Defendants’ positive statements about the Company’s business, operations, and prospects were materially misleading and/or lacked a reasonable basis at all relevant times.

If you purchased or otherwise acquired Kyndryl securities during the Class Period, you may move the Court no later than April 13, 2026 to request appointment as lead plaintiff in this putative class action lawsuit.

Contact Us To Participate or Learn More:
If you wish to learn more about this action, or if you have any questions concerning this announcement or your rights or interests with respect to these matters, please contact us:
Charles Linehan, Esq.,
Glancy Prongay Wolke & Rotter LLP,
1925 Century Park East, Suite 2100,
Los Angeles California 90067
Email:  shareholders@glancylaw.com
Telephone: 310-201-9150,
Toll-Free: 888-773-9224
Visit our website at www.glancylaw.com.
Follow us for updates on LinkedIn, Twitter, or Facebook.

If you inquire by email, please include your mailing address, telephone number and number of shares purchased.

To be a member of the class action you need not take any action at this time; you may retain counsel of your choice or take no action and remain an absent member of the class action.
This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.

Contact Us:
Glancy Prongay Wolke & Rotter LLP,
1925 Century Park East, Suite 2100
Los Angeles, CA 90067
Charles Linehan
Email:  shareholders@glancylaw.com
Telephone: 310-201-9150
Toll-Free: 888-773-9224
Visit our website at: www.glancylaw.com.

Vallourec, a world leader in premium seamless tubular solutions, announces today its results for the fourth quarter 2025. The Board of Directors of Vallourec SA, meeting on February 26^th 2026, approved the Group’s fourth quarter 2025 Consolidated Financial Statements. 

Fourth Quarter 2025 Results

• Q4 Group EBITDA of €214 million, strong 21% EBITDA margin
• Excellent total cash generation of €177 million
• Around €650 million distribution to shareholders targeted by August 2026^a
• Q1 2026 Group EBITDA expected to range between €165 million and €195 million
• Resilient US customer demand while imports continue to decline
• Early signs of activity rebound in key Middle East markets

HIGHLIGHTS

Fourth Quarter 2025 Results

• Group EBITDA of €214 million, up 2% sequentially, EBITDA margin remained strong at 21%
  • Tubes EBITDA per tonne of €548 down (12%) sequentially reflecting negative mix effects
  • Mine & Forest EBITDA at €38 million increasing sequentially by 10%, reflecting higher iron ore market prices partially offset by seasonally lower volumes
• Adjusted free cash flow of €204 million; total cash generation of €177 million – aided by robust collections and inventory management
• Ended the period with a net cash position of €39 million, improving by €179 million sequentially

OUTLOOK

First Quarter 2026 Group EBITDA is expected to range between €165 million and €195 million:

• In Tubes, EBITDA per tonne is expected to be broadly in-line with the Q4 2025 level, while volumes are expected to be below the Q4 2025 level.
• In Mine & Forest, production sold is expected to be around 1.4 million tonnes.

Full Year 2026 results are expected to be influenced by the following dynamics:

• North America Tubes:
  • Sustained strength in sales volumes thanks to Vallourec’s market share gains during 2025
  • A slight near-term decrease in US market prices, with improving industry supply-demand conditions leading to potential improvement later in the year
• International Tubes:
  • Lower sales volumes in H1 2026 due to slower bookings in H2 2025
  • An activity recovery in key Middle Eastern markets setting the stage for higher second half volumes
  • Broadly stable market pricing versus the second half of 2025, with discrete customer contracts driving selective price upside
• Slightly lower year over year iron ore production sold (approximately 5.5 million tonnes) due to an improved production process focusing on value over volume

Philippe Guillemot, Chairman of the Board of Directors and Chief Executive Officer, declared: 

“Vallourec delivered robust results once again in the fourth quarter. EBITDA was above the midpoint of our guidance and we produced a solid 21% EBITDA margin. We converted over 80% of EBITDA to cash – a further demonstration of our consistent improvement in working capital management and operational efficiency. After paying over €370 million to our shareholders in 2025, we returned our balance sheet to a net cash position in December.

“From this solid financial base, we will deliver on our commitment to be one of the most shareholder friendly companies in our peer group. We are targeting returns to shareholders of approximately €650 million between January and August 2026, a nearly €280 million increase versus 2025. We have adopted a balanced distribution framework, limiting warrant dilution through buybacks, growing distributions through a targeted interim dividend payment of €1.75 per share in August^b, and maintaining a defensive balance sheet.

“Reflecting on our 2025 results, I am pleased with the many milestones we have achieved. After reaching zero net debt at the end of 2024, we paid a substantial dividend to shareholders for the first time in a decade in 2025. We significantly narrowed the profitability gap with our primary peer to the lowest level since we embarked on the New Vallourec Plan in early 2022. Finally, our consistent improvement in profitability and financial resilience was recognized with Investment Grade credit ratings across all three rating agencies.

“Our focus in 2026 turns to profitable growth through targeted R&D and capital investments to solve the energy challenges of today and tomorrow. In doing so, we will remain committed to our core principles of value over volume and operational excellence. We are investing in value-added capacity enhancements, including our new high-torque threading line in the US and advanced coating capabilities like our Cleanwell® solution. Meanwhile, we are progressing our ambitions in New Energies, with a recently-announced partnership with XGS Energy in the advanced geothermal arena, and a memorandum of understanding with Baker Hughes in the hydrogen space. We are seeing particularly strong momentum in geothermal markets as the industry searches for ways to deliver clean baseload power to meet rapidly growing energy demand, which is accentuated by rapid growth in artificial intelligence and energy‑intensive data centers.

“In the US, our assets remain highly-utilized and recent booking activity remains strong. Industry pricing has softened slightly, but we are encouraged by the downward trend in imports due to Section 232 tariffs and the resilience of our customers’ activity. In International markets, commercial activity remained subdued in the second half of 2025. In the Middle East we are seeing signs of acceleration – especially in markets with higher levels of unconventional activity.

“We see potential for activity to increase in the second semester and beyond as the oil market rebalances, gas-related activity increases and the acceleration of depletion necessitates investments to maintain and grow production.”

The consolidated financial statements are included in the pdf version of the press release.

Key Quarterly Data

INFORMATION AND FORWARD-LOOKING STATEMENTS

This press release includes forward-looking statements. These forward-looking statements can be identified by the use of forward-looking terminology, including the terms as “believe”, “expect”, “anticipate”, “may”, “assume”, “plan”, “intend”, “will”, “should”, “estimate”, “risk” and or, in each case, their negative, or other variations or comparable terminology. These forward-looking statements include all matters that are not historical facts and include statements regarding the Company’s intentions, beliefs or current expectations concerning, among other things, Vallourec’s results of operations, financial condition, liquidity, prospects, growth, strategies and the industries in which they operate. Readers are cautioned that forward-looking statements are not guarantees of future performance and that Vallourec’s or any of its affiliates’ actual results of operations, financial condition and liquidity, and the development of the industries in which they operate may differ materially from those made in or suggested by the forward-looking statements contained in this presentation. In addition, even if Vallourec’s or any of its affiliates’ results of operations, financial condition and liquidity, and the development of the industries in which they operate are consistent with the forward-looking statements contained in this presentation, those results or developments may not be indicative of results or developments in subsequent periods. By their nature, forward-looking statements involve risks and uncertainties because they relate to events and depend on circumstances that may or may not occur in the future. These risks include those developed or identified in the public documents filed by Vallourec with the French Financial Markets Authority (Autorité des marches financiers, or “AMF”), including those listed in the “Risk Factors” section of the Universal Registration Document filed with the AMF on March 27, 2025, under filing number n° D. 25-0192.

Accordingly, readers of this document are cautioned against relying on these forward-looking statements. These forward-looking statements are made as of the date of this document. Vallourec disclaims any intention or obligation to complete, update or revise these forward-looking statements, whether as a result of new information, future events or otherwise, except as required by applicable laws and regulations. This press release does not constitute any offer to purchase or exchange, nor any solicitation of an offer to sell or exchange securities of Vallourec. or further information, please refer to the website https://www.vallourec.com/en.

Future dividends and share buyback authorizations will be assessed on a yearly basis by the Board of Directors taking into account any relevant factor in the future, and will be subject to Shareholders’ approval. The Board of Directors will have discretion to employ share buybacks throughout the year, up to the limits authorized by the relevant resolution approved by the Annual General Meeting.

Presentation of Q4 2025 Results

Conference call / audio webcast on February 27^th at 9:30 am CET

About Vallourec

Vallourec is a world leader in premium tubular solutions for the energy markets and for demanding industrial applications such as oil & gas wells in harsh environments, new generation power plants, challenging architectural projects, and high-performance mechanical equipment. Vallourec’s pioneering spirit and cutting edge R&D open new technological frontiers. With close to 13,000 dedicated and passionate employees in more than 20 countries, Vallourec works hand-in-hand with its customers to offer more than just tubes: Vallourec delivers innovative, safe, competitive and smart tubular solutions, to make every project possible.

Listed on Euronext in Paris (ISIN code: FR0013506730, Ticker VK), Vallourec is part of the CAC Mid 60, SBF 120 and Next 150 indices and is eligible for Deferred Settlement Service.

In the United States, Vallourec has established a sponsored Level 1 American Depositary Receipt (ADR) program (ISIN code: US92023R4074, Ticker: VLOWY). Parity between ADR and a Vallourec ordinary share has been set at 5:1.

Financial Calendar

For further information, please contact:

^a Subject to warrant full exercise before the end of June 2026 and to Board of Directors approval in July. Estimated per share amount is based on assumptions detailed in the Appendix.

^b Subject to warrant full exercise before the end of June 2026 and to Board of Directors approval in July. Estimated per share amount is based on assumptions detailed in the Appendix.

Attachment

• Vallourec Q4 2025 Results Press Release_Final

Source: Crypto Insider

HIGHLIGHTS

• Q4 EBITDA USD 47.8 million and operating cashflow of USD 107.7 million
• 2025 EBITDA USD 240.1 million and operating cashflow of USD 409.2 million
• Equity ratio 30.2% and USD 634.5 million in available liquidity at year-end 2025
• Q4 dividend USD 0.18 per share equivalent to USD 33.2 million
• 2025 dividend USD 67.0 million, fifth consecutive year of increased shareholder distribution
• BW Opal commissioning progressing, targeting 100% production within Q2 2026
• BW Opal transitioning to volume-based rate from mid-March, practical completion expected in Q2 2026
• Limited strategic review ongoing
• Full-year 2026 EBITDA guidance in the range of USD 340-370 million

Commissioning and production ramp-up for BW Opal FPSO continued with BW Offshore receiving a commissioning rate equal to 60% of the contractual dayrate. Commissioning was extended in the fourth quarter by two connection failures on the utilities and firewater seawater piping systems and a campaign to strengthen similar connections across the FPSO. In early 2026, compressor dry-gas seal replacements have impacted production regularity. BW Opal is targeting to reach 100% production capacity within the second quarter of 2026. BW Offshore will transition to a production volume-based dayrate in mid-March, with revenue recognition commencing at that time. Formal practical completion and commencement of the 15-year fixed contract is also expected in the second quarter.

The Board of Directors has declared a quarterly cash dividend of USD 0.18 per share. The shares will trade ex-dividend from 4 March 2026. Shareholders recorded in VPS following the close of trading on Oslo Børs on 5 March 2026, will be entitled to the distribution, payable on or around 13 March 2026. The total dividend for 2025 amounts to USD 67.0 million (USD 0.37 per share) equal to 50% of net income for the year. This is an increase of 12% compared to 2024.

“In 2025, BW Offshore achieved key operational and strategic milestones with first gas from BW Opal, high commercial uptime from the fleet and strong cash flow generation. We also delivered a dividend equal to 50% of net income marking the fifth consecutive year of increased shareholder distributions,” said Marco Beenen, CEO of BW Offshore. “With BW Opal ramping up production, we expect EBITDA growth in 2026. We continue to advance the prestigious Bay du Nord FPSO project with Equinor and with BW Elara we progress growth opportunities within floating transition solutions.”

For 2026, BW Offshore expects to report EBITDA in the range of USD 340-370 million. The outlook reflects firm backlog for BW Adolo and BW Catcher and expected revenue recognition from BW Opal following the transition to volume-based rate from mid-March.

On 5 December 2025, BW Offshore announced the engagement of an external adviser to assist in a strategic review. The process is a response to incoming interest for the Company considering the strong FPSO market. The Company’s main strategic focus of growing the FPSO business supported by an optimised capital structure and strong partnerships remains unchanged.

FINANCIALS
EBITDA for the fourth quarter of 2025 was USD 47.8 million (USD 43.9 million in Q3 2025), reflecting strong operational performance from the fleet. EBIT for the fourth quarter was USD 27.5 million (USD 22.5 million).

Net financial items were negative at USD 0.5 million (positive USD 6.7 million).

Loss from equity-accounted investments was USD 1.9 million (loss of USD 3.6 million), including a valuation adjustment on the Barossa finance receivable related to changes in timing of future cash flows.

Tax expense was USD 1.0 million (USD 2.3 million).

Net profit for the fourth quarter was USD 24.1 million (USD 23.3 million).

On 31 December 2025, total equity was USD 1 293.0 million (USD 1 273.9 million), and the equity ratio was 30.2% (30.5%).

As a result of strong cash generation from the fleet and asset sales in recent quarters, the Company was net cash positive by USD 211.8 million (USD 186.6 million) as of 31 December 2025.

Available liquidity was USD 634.5 million, excluding consolidated cash from BW Ideol and including USD 220 million available under the undrawn revolving credit facility.

FPSO OPERATIONS
The FPSO fleet continued to deliver stable operations in the quarter with a weighted average fleet uptime of 100% (98.7% in Q3 2025).

On 31 December 2025, the firm and probable backlog measured by expected cashflow from operations amounted to USD 2.2 billion (USD 2.1 billion).

FPSO PROJECTS
BW Offshore continued to progress all technical and commercial discussions on schedule for the Bay du Nord FPSO under the Heads of Agreement signed with Equinor in September. The pre-FEED and bridging phases have been completed, and the FEED is planned to commence in the first half of 2026, subject to final agreements with Equinor. The process for ordering major long-lead equipment packages is underway and the Company expects to open a local office in St. John’s, Canada, during the first half of 2026.

FLOATING TRANSITION SOLUTIONS
BW Offshore now holds 68% of BW Ideol following a strategic partnership with Holcim in December. This transaction, which includes a capital increase, funds operations for the upcoming year. Operationally, the three floaters for the 30 MW Eolmed wind pilot project were completed with turbines and are now enroute for connection and commissioning. Additionally, the Fos3F project, for developing a fabrication line for concrete floating foundations, secured combined grants of EUR 127 million from the EU Innovation Fund and the French Government.

The BW Elara joint venture, created by BW Offshore and an affiliate BW Group to design and build Floating Desalination Units (FDUs), progressed towards investment decision for the first unit in 2026. In parallel, there was high commercial activity across target markets. The FDUs will be delivered through a flexible service supply model.

OUTLOOK
BW Offshore expects that the current fleet will continue to generate significant cash flow in the time ahead, supported by the firm contract backlog. Furthermore, growing energy demand continues to drive demand for developing new FPSO projects with long production profiles, low break-even costs and reduced emissions.

Increased project complexity and higher construction costs necessitates financial structures with significant day rate prepayments during the construction period for new lease and operate projects. Alternatively, oil and gas companies may finance and own FPSOs, relying on FPSO specialists for the design, construction and installation scope, combined with operation and maintenance services. BW Offshore is well positioned to offer both solutions.

After an extended period with FPSO project sanctions lagging expectations there is a historically high number of projects at various stages of maturity, reflected in increased FEED and tendering activity. The Company continues to selectively evaluate new projects that meet required return targets, offer contracts with no residual value risk after firm period, and provide a financeable structure with strong national or investment grade counterparties.

BW Offshore expects that a number of the FPSO projects the Company is engaging with will reach a final investment decision over the next 12 to 36 months.

Current market dynamics and the high competence levels required for project execution should enable better risk-reward and improved margins for FPSO companies going forward. Furthermore, BW Offshore is evolving its project execution model focused on strong partnerships for the design, engineering and construction phases and overall strengthened risk management. The same principles are also applied to new business opportunities within floating transition solutions.

Please see the attached the fourth quarter presentation and 2025 Annual Report and Sustainability Statement. The earnings tables are available at:

https://bwoffshore.com/financials

BW Offshore will host a webcast of the financial results 09:00 (CET) today. The presentation will be given by CEO Marco Beenen and CFO Ståle Andreassen.

Webcast information:
You can follow the presentation via webcast with supporting slides and a Q&A module, available on:

BW Offshore Limited – Q4 presentation webcast

Please note, that if you follow the webcast via the above URL, you will experience a 30 second delay compared to the main conference call. The web page works best in an updated browser – Chrome is recommended.

For further information, please contact:
Ståle Andreassen, CFO, +47 91 71 86 55
IR@bwoffshore.com or www.bwoffshore.com

About BW Offshore:
BW Offshore engineers innovative floating production solutions. The Company has a fleet of FPSOs and floating wind solutions. By leveraging four decades of offshore operations and project execution, the Company creates tailored offshore energy solutions for evolving markets worldwide. BW Offshore has around 900 employees and is publicly listed on the Oslo stock exchange.

This information is subject to the disclosure requirements pursuant to section 5-12 of the Norwegian Securities Trading Act.

Attachments

Source: Crypto Insider

Akron, OH, Feb. 26, 2026 (GLOBE NEWSWIRE) — This article is for informational purposes only. The Herz P1 Smart Band is a consumer wellness product and is not a medical device. It is not intended to diagnose, treat, cure, or prevent any disease or medical condition. Consumers should consult a qualified healthcare professional before making health decisions based on data from any wearable device. This article contains affiliate links. If you click through and make a purchase, a commission may be earned at no additional cost to you. This compensation does not influence the accuracy or integrity of the information presented.

The consumer wearable market continues to expand in 2026, with fitness trackers, smart bands, and health monitoring devices competing for attention across a crowded category. For consumers researching their options, sorting through feature claims, pricing models, and subscription structures can feel overwhelming. The Herz P1 Smart Band is one product that’s entered this space, marketed as a subscription-free wrist-worn health tracker with a long battery life and multi-metric monitoring capabilities.

This informational overview examines what the Herz P1 Smart Band offers, how its features are described by the company, what the pricing structure looks like, and what consumers should independently verify before purchasing any fitness wearable in this category. The wearable technology space moves quickly, and product specifications, pricing, and availability can change without notice.

Any product details are described as stated by the company and should be verified on the official site and directly with the manufacturer.

The Herz P1 Smart Band is a consumer wellness product, not an FDA-cleared or FDA-approved medical device, and health monitoring results are not guaranteed.

The information below is compiled from publicly available materials and does not represent clinical evaluation, independent laboratory testing, or editorial endorsement of the product or company.

To view the current Herz P1 Smart Band offer (official Herz P1 page), consumers can check the complete product details, pricing, and return policy directly.

What the Herz P1 Smart Band Is

The Herz P1 Smart Band is a wrist-worn consumer wellness and fitness tracker manufactured by WuzuTech LLC, a company based in Akron, Ohio. The company positions the device as a general wellness tool designed for continuous 24/7 health monitoring. It is not classified as a medical device, and the company’s own health disclaimer states that the product and related services “are for general wellness and fitness purposes only and are not intended to be used as a medical device or to replace professional medical advice, diagnosis, or treatment.”

The company states that the Herz P1 Smart Band tracks over 20 health and activity metrics using optical heart rate sensors, motion sensors, and temperature sensors built into the device. Data from the band syncs to the Herz companion app, which is available on both iOS and Android.

Per the company’s published materials, the device is a one-time purchase with no recurring subscription fees required to access health data or app features. Wearable products in this category use different pricing and app-access models — some include subscription-based features, while others are offered as one-time purchases. Consumers can verify current access terms on the official product page.

Regulatory Classification and General Wellness Wearables

In the United States, some consumer wearables are marketed as “general wellness” products. The FDA has published guidance describing its enforcement policy for low-risk general wellness products and how they differ from devices intended for diagnosis or treatment. These products may provide estimates and trend insights related to activity and wellness but aren’t intended to diagnose, treat, cure, or prevent disease.

The company markets the Herz P1 Smart Band for general wellness and fitness purposes, and states it is not intended to be used as a medical device or to replace professional medical advice. This means the data it provides — heart rate estimates, sleep pattern approximations, SpO2 readings, and activity metrics — should be understood as trend indicators, not clinical measurements.

Consumers should avoid using wearable readings as a substitute for clinical evaluation, especially for medical decisions involving heart conditions, oxygenation concerns, unusual temperature patterns, or sleep disorders. Anyone with specific health concerns should consult a licensed healthcare provider who can recommend appropriate monitoring tools.

How the Herz P1 Smart Band Works

The company’s materials describe the device as using a combination of sensor technologies to collect biometric and activity data from the wearer’s wrist throughout the day and night. The collected data is transmitted via Bluetooth to the Herz companion app (also referenced as QRing), where it’s organized into reports and insights.

Optical Heart Rate Sensors — the company states these continuously monitor heart rate and heart rate variability (HRV), providing data on cardiovascular patterns during both active and resting periods.

Motion Sensors — accelerometer technology is described as tracking steps, distance, calories burned, and activity intensity throughout the day.

Temperature Sensors — the company’s documentation references continuous skin temperature monitoring, which is described as helping users identify patterns related to recovery and overexertion.

Blood Oxygen (SpO2) Monitoring — the device is described as measuring blood oxygen saturation levels, which the company frames as relevant to understanding energy levels and respiratory patterns.

Per the company’s website, the band also includes stress tracking capabilities and sleep analysis features that monitor sleep stages and quality metrics overnight.

What the Herz P1 Smart Band Tracks

Based on publicly available information from the company, the Herz P1 Smart Band is described as monitoring the following categories of health and activity data:

Heart Rate and HRV — continuous heart rate monitoring and heart rate variability tracking, which the company describes as useful for understanding recovery and cardiovascular health patterns over time.

Sleep Quality and Analysis — the company states the band monitors sleep patterns overnight and provides sleep quality insights through the companion app.

Blood Oxygen (SpO2) — the device is described as tracking blood oxygen saturation, with data accessible through the app.

Skin Temperature — continuous temperature monitoring is referenced in the company’s feature descriptions.

Stress Tracking — the company’s materials describe real-time stress monitoring that shows when the body is under strain and how it recovers.

Activity Metrics — steps, distance, and calories burned are described as core tracking features.

Women’s Health Insights — the company references menstrual cycle tracking capabilities that provide insights into how the cycle affects energy, sleep, and mood.

All tracking capabilities described above come from the manufacturer’s publicly available materials. Wrist-worn consumer wellness devices use sensor technologies that provide estimates and trend data — not clinical measurements. Accuracy can vary based on device fit, skin type, motion, environmental conditions, and individual physiology. Consumers who need medically reliable biometric data should consult with a healthcare provider about appropriate monitoring tools.

Pricing and Purchase Structure

The Herz P1 Smart Band is sold as a one-time purchase through the company’s official website. Wearable products in this category use different pricing models — some require recurring subscriptions to unlock full feature access, while others include all features with a one-time purchase. The company states the Herz P1 Smart Band doesn’t require a recurring subscription to access its companion app features.

According to publicly available information on the official website at the time of publication, pricing may vary based on promotions, bundles, and inventory conditions. Consumers should check the official Herz P1 page to confirm the most current pricing, shipping costs, and policy terms before making any purchase decision.

The company’s materials state that the purchase includes the smart band, charging cable, and straps. Additional color bands may be sold separately.

The company references a 90-day return policy on its official page. Consumers should verify eligibility requirements, timelines, and return shipping responsibilities directly in the published policy before purchasing.

Battery Life, Build Quality, and Design

The company states the Herz P1 Smart Band contains a 175 mAh battery and describes the following performance characteristics:

Active Use Battery Life — the company states up to 25–30 days of regular use on a single charge.

Standby Battery Life — up to 60 days of standby time is referenced in the company’s materials.

Charging Time — the company states the device fully recharges in approximately 1 to 1.5 hours.

Regarding build quality, the company’s documentation describes the device as constructed from a lightweight zinc alloy frame with a durable nylon strap. The company states the band is water-resistant and sweat-proof, suitable for workouts and daily wear. The company’s official product page references water resistance but advises against swimming or full submersion.

The Herz P1 Smart Band is described as available in five color options: Midnight Black, Frosted White, Green Power, Navy Blue, and Rose Mist.

Battery life and water resistance claims come from the manufacturer. Actual performance may vary based on notification settings, sensor sampling frequency, Bluetooth connectivity, display behavior, device fit, and environmental conditions. Consumers should check the complete product specifications on the official site before purchasing.

Companion App and Data Access

The company states that the Herz P1 Smart Band syncs with a companion app available for both iOS and Android. The app is described as providing detailed health and fitness reports, goal-setting features, and progress tracking over time. Per the company’s materials, the app supports over 30 languages.

The band also includes offline data storage. The company states that if Bluetooth is disconnected, the device can store health data locally for several days. Once reconnected, stored data syncs automatically with the companion app.

Consumers should verify app compatibility with their specific device and operating system version before purchasing.

What Consumers Commonly Verify Before Purchasing

Based on common consumer research patterns in the wearable technology category, here are areas that prospective buyers typically investigate before purchasing a fitness tracker:

Accuracy Expectations: Consumer wellness wearables vary in accuracy across different metrics. No wrist-worn consumer device provides clinical-level precision. The company states its device tracks various metrics, but consumers seeking medically reliable data should consult a healthcare provider.

Return Policy Terms: The company references a 90-day return policy on its official page. Consumers should verify the specific terms, conditions, and process for returns directly on the company’s website before purchasing.

Company Background: WuzuTech LLC is listed as the manufacturer, based in Akron, Ohio. Consumers can verify the company’s business registration, customer service responsiveness, and fulfillment track record independently.

App Functionality: Checking the companion app’s current version, update frequency, and user feedback in the iOS App Store or Google Play Store before purchasing can provide additional perspective on the overall experience.

Comparison Shopping: Consumers often compare wearables based on sensor types, sampling frequency, battery life under real-world settings, return policy clarity, app permissions, and whether full feature access requires ongoing fees. Evaluating multiple products across these criteria helps inform a purchasing decision.

Water Resistance vs. Waterproofing: The company describes the device as water-resistant and suitable for sweat and splashes but advises against swimming or full submersion. Consumers should understand the difference between water resistance ratings before wearing any device in water.

Key Terminology for the Consumer Wearable Category

Heart Rate Variability (HRV): HRV measures the time variation between heartbeats. In consumer wellness contexts, it’s commonly used as an indicator of recovery and stress. HRV readings from consumer wearables are estimates and shouldn’t be used for medical diagnosis.

Blood Oxygen Saturation (SpO2): SpO2 refers to the percentage of oxygen-carrying hemoglobin in the blood. Consumer wearable SpO2 readings are approximations and aren’t equivalent to pulse oximeter readings obtained in clinical settings.

Photoplethysmography (PPG): PPG is the optical sensor technology commonly used in consumer wearables to detect blood volume changes beneath the skin. It’s the foundational technology behind heart rate and SpO2 monitoring in most fitness trackers and smart bands.

General Wellness Device: A category described in FDA guidance for products intended to promote a healthy lifestyle. General wellness devices aren’t intended to diagnose, treat, cure, or prevent disease and don’t follow the same regulatory pathway as medical devices.

Subscription-Free Model: In the wearable category, some manufacturers require monthly or annual subscriptions to access full data insights and features. Subscription-free models provide full feature access with a one-time purchase.

Fitness Tracker vs. Smartwatch: A fitness tracker or smart band typically focuses on health and activity monitoring with a lighter design and longer battery life. Smartwatches generally offer broader app functionality, larger displays, and shorter battery life. The Herz P1 Smart Band falls into the fitness tracker and smart band category.

Consumer Questions About the Herz P1 Smart Band

Is the Herz P1 Smart Band a medical device?

No. The company explicitly states that the Herz P1 Smart Band is a general wellness and fitness product. It isn’t intended to diagnose, treat, cure, or prevent any disease or medical condition. The company’s health disclaimer directs consumers to consult a qualified healthcare professional for medical advice.

Who manufactures the Herz P1 Smart Band?

The Herz P1 Smart Band is manufactured by WuzuTech LLC, a company based in Akron, Ohio. Consumers can verify the company’s business details and contact information independently.

Does the Herz P1 Smart Band require a monthly subscription?

The company states that no subscription is required. All health data and app features are described as accessible with the one-time device purchase. Consumers should verify this on the official website, as company policies can change.

What phone compatibility does the Herz P1 Smart Band support?

The company states the device works with both iOS and Android devices through a free companion app. Consumers should verify specific operating system version requirements before purchasing.

How long does the Herz P1 Smart Band battery last?

The company states up to 25–30 days of regular use on a single charge, with up to 60 days of standby time. Actual battery performance may vary based on usage patterns and settings. The company states charging takes approximately 1 to 1.5 hours.

Is the Herz P1 Smart Band waterproof?

The company describes the device as water-resistant and suitable for sweat, rain, and hand-washing. However, the company advises against swimming or fully submerging the device. Consumers should check the specific water resistance rating on the official product page.

What metrics does the Herz P1 Smart Band track?

The company states the device tracks over 20 health and activity metrics, including heart rate, HRV, SpO2, temperature, sleep quality, stress levels, steps, distance, and calories burned. All accuracy claims come from the manufacturer.

Does the Herz P1 Smart Band store data offline?

The company states the device can store health data locally for several days if Bluetooth is disconnected. Stored data syncs automatically once Bluetooth is reconnected.

What is the return policy for the Herz P1 Smart Band?

The company references a 90-day return policy on its official page. Consumers should verify eligibility requirements, timelines, and return shipping responsibilities directly in the published policy before purchasing.

How does the Herz P1 Smart Band compare to smartwatches?

Smart bands and smartwatches serve different purposes. Smart bands like the Herz P1 generally focus on health and fitness tracking with lighter designs and longer battery life. Smartwatches typically offer broader app ecosystems, larger displays, notification management, and shorter battery life. The right choice depends on individual priorities and what you’re looking for in a wearable.

Where can consumers purchase the Herz P1 Smart Band?

The company’s official website is the primary direct purchase channel. The product has also been listed on third-party retail platforms. Consumers should verify they’re purchasing from an authorized source.

What colors are available for the Herz P1 Smart Band?

The company’s materials reference five color options: Midnight Black, Frosted White, Green Power, Navy Blue, and Rose Mist. Availability may vary.

Additional Category Context

Consumers researching subscription-free fitness trackers often evaluate several areas beyond any single product’s feature list. Understanding how optical wrist sensors estimate heart rate and SpO2, what app privacy and data permissions look like, how battery life performs under real-world conditions, and what return and warranty terms actually require are all part of informed decision-making in this category.

This article focuses on those evaluation areas using publicly available product disclosures from the Herz P1 Smart Band manufacturer. Consumers are encouraged to apply the same research approach across any wearable they’re considering.

For additional context on the broader Herz P1 product line, a separate informational overview examines the company’s smart ring offering — including its features, pricing, accuracy context, and what consumers should verify before purchasing. Read the full informational analysis here.

A separate informational overview also examines the company’s smart scale product, including its 8-electrode BIA sensor technology, body composition metrics, and what consumers should verify about accuracy claims for any home health measurement device. Read the full informational overview here.

Both analyses were published for informational purposes and are not endorsements or recommendations.

A Consumer Verification Checklist for Any Health-Tracking Wearable

Before purchasing any health-tracking wearable — including the Herz P1 Smart Band — consumers can strengthen their decision-making by independently verifying the following areas. This checklist isn’t specific to any single product. It’s a framework that applies across the entire consumer wearable category.

Verify the App Name and Developer: Download and check out the companion app before purchasing the hardware. Look at who developed it, when it was last updated, and what the current user feedback looks like. The Herz P1 Smart Band syncs with an app referenced as the Herz app or QRing, available on iOS and Android.

Check App Permissions: Before installing any health-tracking app, look at what data permissions it requests. Common requests include Bluetooth, location, health data access, and notification permissions. Understand what data the app collects and how it’s stored or shared.

Confirm Data Export Options: Some consumers want to export their health data to share with healthcare providers or use with other platforms. Check whether the companion app allows data export and in what formats before committing to a device ecosystem.

Read the Return Policy in Full: Don’t rely on summary language. Read the actual return policy terms, including who pays return shipping, whether the device must be in original packaging, and how refunds are processed. The company states a return policy is available on the official Herz P1 website.

Check Warranty Terms: Look at what the warranty covers, how long it lasts, and what the claims process involves. Manufacturer warranties for consumer electronics vary significantly in scope and responsiveness.

Understand Sensor Limitations: Consumer wearables use optical sensors (PPG), accelerometers, and temperature sensors that provide estimates — not clinical measurements. Factors like skin tone, tattoos, wrist fit, motion, and environmental temperature can affect reading accuracy across all consumer wearable brands.

Clarify Water Resistance vs. Waterproofing: These terms mean different things. Check the specific rating. The Herz P1 Smart Band is described as water-resistant and suitable for sweat and splashes, but the company advises against swimming or full submersion.

Test Customer Support Responsiveness: Before purchasing, consider sending a pre-sale question to the company’s support team. Response time and quality can give you a sense of what post-purchase support looks like.

Ask About Firmware Updates: Wearable devices often receive firmware updates that can affect performance, features, and battery life. Check whether the manufacturer has a track record of providing updates and how they’re delivered.

Confirm Device Compatibility: Verify that your specific phone model and operating system version are compatible with the companion app before purchasing. Compatibility requirements can change with operating system updates.

Summary of Key Considerations

The Herz P1 Smart Band enters 2026 as a subscription-free consumer wellness wearable in a crowded fitness tracker category. The company’s advertised feature set — including 20+ health metrics, up to 30-day battery life, and no recurring fees — positions it as one option among many for consumers exploring accessible health monitoring.

As with any consumer wellness device, prospective buyers should understand that the Herz P1 Smart Band is not a medical device and shouldn’t be used as a substitute for professional medical advice, diagnosis, or treatment. All feature claims, accuracy statements, and performance specifications referenced in this article come from the manufacturer’s publicly available materials and haven’t been independently verified through clinical testing as part of this overview.

Consumers interested in the complete product details, current pricing, and return policy can view the current Herz P1 Smart Band offer (official Herz P1 page) directly.

Contact Information

WuzuTech LLC

839 E Market St, Ste 106 #165

Akron, OH 44305

United States

Email: support@wuzutech.com

Phone: (866) 479-1629

Website: https://herzp1.com

Disclaimers

Content and General Wellness Disclaimer: This article is for informational purposes only and does not constitute medical advice, professional health guidance, or a product endorsement. The Herz P1 Smart Band is a consumer wellness product, not a medical device. Statements regarding the product have not been evaluated by the Food and Drug Administration. The device is not intended to diagnose, treat, cure, or prevent any disease or medical condition. Consumers should consult with a qualified healthcare professional before making health-related decisions based on data from any consumer wearable device. All product descriptions, features, and specifications referenced in this article are based on the manufacturer’s publicly available materials and have not been independently verified through clinical testing.

Results, Pricing, and Availability Notice: Individual results and experiences with consumer wellness wearables vary based on usage patterns, device fit, individual physiology, environmental conditions, and other factors. No specific outcomes are guaranteed. Pricing referenced in this article reflects publicly available information at the time of publication and is subject to change without notice. Consumers should verify all current pricing, shipping costs, and return policy terms directly on the company’s official website before purchasing.

FTC Affiliate Disclosure and Publisher Responsibility: This article contains affiliate links. If you click through these links and make a purchase, a commission may be earned at no additional cost to you. This affiliate relationship does not influence the informational content, accuracy, or editorial independence of this article. The publisher is not responsible for the accuracy of information provided by the manufacturer, changes to the product or its availability, or the consumer’s individual experience with the product or company. Consumers are encouraged to conduct their own research and due diligence before making any purchase decision.

CONTACT: Email: support@wuzutech.com
Phone: (866) 479-1629

Image by My Future Purpose

WESTON, Conn., Feb. 26, 2026 (GLOBE NEWSWIRE) — My Future Purpose, a purpose-driven organization dedicated to lifelong reinvention and civic engagement, today announces the release of From Woodstock to Wisdom: A Boomer’s Journey to 80 by Chief Purpose Officer Vicki Thomas. The book calls on Baby Boomers to embrace their legacy, remain visible, and actively contribute to democracy. In an era of longer life spans, extended careers, and evolving social roles, Thomas encourages her generation to redefine aging as a time of renewed purpose, societal engagement, and personal impact.

Connecting the Past to Today

In her book, Thomas links the cultural activism of the 1960s to today’s opportunities for civic engagement. The work reframes aging not as a period of decline but as one of renewed responsibility, relevance, and contribution.

“For Baby Boomers, music was never just background noise; it was instruction,” Thomas says. “Songs taught us to question authority, to imagine a just society, and to believe that we could change the world when we raised our voices together. Those lessons still matter today.”

From Woodstock to Wisdom underscores that purpose does not retire, and silence is not neutral. Thomas draws a clear connection between the activism of her generation and contemporary challenges, highlighting how reinvention later in life can be both a personal renewal and an act of civic responsibility.

“Purpose does not retire, and silence is not neutral,” Thomas emphasizes. “As we age, we can continue to be relevant, visible, and active in defending the democratic values we once fought for.”

The book also addresses the urgent need for intergenerational leadership, noting the unique contributions older adults bring to public discourse. It speaks to those navigating the complexities of aging, caregiving, technology, financial uncertainty, and the desire to remain an active and useful member of society. Rather than offering nostalgia, Thomas’s work is a call to action: age purposefully, visibly, and unapologetically.

Availability

From Woodstock to Wisdom is now available for purchase through Amazon, Barnes & Noble, and other major booksellers.

About Vicki Thomas

Vicki Thomas is Chief Purpose Officer of My Future Purpose and a passionate advocate for purpose-driven living, community engagement, and lifelong reinvention. Through her writing and speaking, Thomas encourages individuals and organizations to align values with action, recognizing that experience should not be something to step away from, but something to stand on.

Media Contact:
My Future Purpose
203-339-2000
vicki@myfuturepurpose.com
https://www.myfuturepurpose.com/

A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/8595d625-2e07-4956-85e1-cfed277f8261.